MedPath

Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant Therapy

Completed
Conditions
Disseminated HER2+ Breast Cancer
Registration Number
NCT01645059
Lead Sponsor
Asociación Cacereña para la Investigación y el Desarrollo en Oncología Médica
Brief Summary

This is an observational, cross-sectional study that the main objective is to describe the patient clinical profile that begins with disseminated Her 2+ Breast Cancer or develops a metastasis after or during the adjuvant treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
129
Inclusion Criteria
  • Women with 18 years or over
  • Patients with disseminated breast cancer histologically or cytological confirmed, who begins with Her 2+ metastatic breast cancer or develops a metastasis after or during the adjuvant therapy
  • Patients treated in first line treatment in metastatic disease.
  • Patients who have positive Her 2 receptor test
  • Patients who have given their written informed consent
Exclusion Criteria
  • Patients who are participating in other studies

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Patient Clinical Profile (General Clinical Data and Breast Cancer Characteristics)1 day (there is no follow-up, it is a cross-sectional study)

General clinical data: age, weigh, height, Perfomance Status (ECOG Eastern Cooperative Oncology Group, runs from 0 to 5, with 0 denoting perfect health and 5 death), Breast cancer characteristics: familiar history of breast cancer, initial diagnostic (localized or disseminated), age at diagnostic, TNM (tumor node metástasis), tumor size, node involvement, primary tumor surgery, HER2 overexpression, histological Classification (grades I, II and III,determines the urgency and aggressiveness of treatment, as the higher grades do tend to correspond to poorer survival rates and prognosis), time from the primary breast cancer to distant relapse, description and localization of metastasis

Secondary Outcome Measures
NameTimeMethod
Adjuvant Treatment-Node Affectationone day (there is no follow-up, it is a cross-sectional study)

Adjuvant treatment and clinical profile (Node affectation)

The patients analysed in this outcome are patients initially diagnosed with localized breast cáncer (N=66)

Adjuvant Treatment in Primary Breast Cancer: Chemotherapy (Treatment With TAC-Docetaxel, Adriamicine and Cyclophosphamide), Hormonal Therapy Anti-HER Biological Therapyone day (there is no follow-up, it is a cross-sectional study)
Disseminated Breast Cancer Treatment-Smokingone day (there is no follow-up, it is a cross-sectional study)

Analyse disseminated Breast Cancer treatment and clinical profile (Smoking)

Adjuvant Treatment and Ageone day (there is no follow-up, it is a cross-sectional study)

Adjuvant treatment and clinical profile (age)

The patients analysed in this outcome are patients initially diagnosed with localized breast cáncer (N=66)

Adjuvant Treatment-Physical Activityone day (there is no follow-up, it is a cross-sectional study)

Adjuvant treatment and clinical profile (Physical activity)

The patients analysed in this outcome are patients initially diagnosed with localized breast cáncer (N=66)

Disseminated Breast Cancer Treatment-Ageone day (there is no follow-up, it is a cross-sectional study)

Analyse disseminated Breast Cancer treatment and clinical profile (age)

The Pattern of Treatment in Metastatic Breast Cancer: Chemotherapy, Hormonal Therapy Anti-HER Biological Therapyone day (there is no follow-up, it si a cross-sectional study)
Disseminated Breast Cancer Treatment-physical Activityone day (there is no follow-up, it is a cross-sectional study)

Analyse disseminated Breast Cancer treatment and clinical profile (physical activity)

Trial Locations

Locations (39)

Hospital de Móstoles

🇪🇸

Móstoles, Madrid, Spain

Hospital de Getafe

🇪🇸

Getafe, Madrid, Spain

Hospital Virgen del Puerto

🇪🇸

Plasencia, Cáceres, Spain

Hospital de Torrecárdenas

🇪🇸

Almería, Spain

Hospital Universitario de la Candelaria

🇪🇸

Santa Cruz de Tenerife, Tenerife, Spain

Hospital de Alcañiz

🇪🇸

Alcañiz, Teruel, Spain

Hospital de Galdakao

🇪🇸

Galdakao, Vizcaya, Spain

Hospital Reina Sofía de Tudela

🇪🇸

Tudela, Navarra, Spain

Hospital de Jerez

🇪🇸

Jerez de la Frontera, Cádiz, Spain

Clínica Corachan

🇪🇸

Barcelona, Spain

Hospital Infanta Cristina de Badajoz

🇪🇸

Badajoz, Spain

Hospital General Universitario de Valencia

🇪🇸

Valencia, Spain

Hospital Universitario de Canarias

🇪🇸

La Laguna, Tenerife, Spain

Hospital Severo Ochoa

🇪🇸

Leganés, Madrid, Spain

Hospital do Meixoeiro

🇪🇸

Vigo, Pontevedra, Spain

Complejo Hospitalario Ciudad Real

🇪🇸

Ciudad Real, Spain

Hospital La Princesa

🇪🇸

Madrid, Spain

Hospital de Zamora

🇪🇸

Zamora, Spain

Hospital San Pedro Alcántara

🇪🇸

Cáceres, Spain

Hospital Virgen de la Macarena

🇪🇸

Sevilla, Spain

Hospital Quirón

🇪🇸

Pozuelo de Alarcón, Madrid, Spain

Hospital don Benito

🇪🇸

Don Benito, Badajoz, Spain

Hospital General de l'Hospitalet

🇪🇸

Hospitalet de Llobregat, Barcelona, Spain

Hospital Morales Messeguer

🇪🇸

Murcia, Spain

Hospital Dr.Peset

🇪🇸

Valencia, Spain

Hospital Clínico de Valladolid

🇪🇸

Valladolid, Spain

Hospital Universitario Rio Hortega

🇪🇸

Valladolid, Spain

Hospital de Txagorritxu

🇪🇸

Vitoria, Álava, Spain

Hospital de Mérida

🇪🇸

Mérida, Badajoz, Spain

Hospital de Denia

🇪🇸

Denia, Alicante, Spain

Hospital General de Elda

🇪🇸

Elda, Alicante, Spain

Hospital de Cabueñes

🇪🇸

Gijón, Asturias, Spain

Hospital de Llerena

🇪🇸

Llerena, Badajoz, Spain

ICO Badalona

🇪🇸

Badalona, Barcelona, Spain

Hospital Son Llàtzer

🇪🇸

Palma de Mallorca, Islas Baleares, Spain

Hospital Lucus Augusti

🇪🇸

Lugo, Spain

Hospital de León

🇪🇸

León, Spain

Hospital General de Segovia

🇪🇸

Segovia, Spain

Hospital Universitario Arnau de Vilanova

🇪🇸

Lleida, Spain

© Copyright 2025. All Rights Reserved by MedPath